Cancer FDA approves first drug to treat rare adrenal cancer Azedra has received FDA approval to become the first and only treatment for a type of rare adrenal cancer.
News UK's Claret Capital raises €575m for European biotechs London-based Claret Capital Partners has closed its fourth European Growth Capital Fund, raising €575m for "Europe's boldest innovators."
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
